September 30, 2008 - New research shows cardiac resynchronization therapy (CRT) reduced the time to first heart failure hospitalization or death by nearly half in patients with mild heart failure, and devices equipped with OptiVol Fluid Status Monitoring identified patients who were at a significantly higher risk (3.5 times) of having a heart failure event in the near future.

September 30, 2008 - Endovascular aneurysm repair (EVAR) yields better results than open surgical repair (OSR) in high-risk patients with similar costs, according to a one-year trial study, which appears in the October issue of the Journal of Vascular Surgery, published by the Society for Vascular Surgery.

September 26, 2008 - TyRx Inc. announced today the launch of AIGISRX ICD, an anti-bacterial envelope developed to help reduce surgical site infections and create a stable environment for implantable cardioverter defibrillators (ICDs).

The launch of AIGISRX ICD extends TyRx's AIGISRX CRMD (cardiac rhythm management device) platform to the implantable cardioverter defibrillator market. The AIGISRX CRMD platform also includes AIGISRX PM, the Company's anti-bacterial coated mesh designed specifically for implanted pacemakers.

ZONARE's new cardiology option for the z.one ultra system, which incorporates Zone Sonography technology, allows cardiologists to perform the same full diagnostic exam that is comparable to those done with large 300 to 400-pound systems.

September 26, 2008 - CryoCath Technologies Inc. announced yesterday it has resolved all outstanding patent suits among the company and Boston Scientific Corp., its wholly-owned subsidiary, CryoCor Inc., and CryoCor's co-plaintiff/co-defendant AMS Research Corp.

September 26, 2008 - Boston Scientific Corp. today announced the grand opening of the International Institute for Therapy Advancement in Paris, dedicated to providing world-class training and education to help healthcare professionals advance the standard of patient care.
The 3,000 square-meter facility is said to offer the latest in modern medical training and current clinical science focused on cardiac and vascular therapies.

September 26, 2008 - The 6th annual Medical Innovation Summit at Cleveland Clinic is scheduled for Nov. 10-12 in Cleveland, OH.

More than 900 senior executives, investors, entrepreneurs and clinicians are expected to attend.

The summit will feature:

- Detailed insights into the newest innovations in the fast growing urology and gynecology markets including live, interactive surgery

- “Top 10” medical innovations for 2009

- Analysis on new directions for supporting innovation

For more information: www.clevelandclinic.org/innovations/summit/

Carestream Health's SuperPACS architecture allows healthcare providers to efficiently connect disparate PACS at multiple sites throughout a healthcare system.

September 25, 2008 - Boston Scientific Corp. announced it has received approval from the FDA to market its TAXUS Express2 Atom paclitaxel-eluting coronary stent system, a drug-eluting stent (DES) specifically designed for treating small coronary vessels.

The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, stated Boston Scientific.

September 25, 2008 - The Global Markets for Cardiac Rhythm Management (CRM) Devices 2009 report by Millennium Research Group (MRG) shows the CRM device market has recovered after a slump caused by several device recalls that began in 2005, and that the market will continue its recovery and growth over the next five years due largely to implantable defibrillator sales, which include implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now